Contact Us Our Blog & News Updates Best Peptide Storage Practices for Research Labs Best peptide storage practices protect research material from heat, moisture, light, and handling variability, supporting [...] Aug How to Verify Peptide Purity Before Research Learn how to verify peptide purity using COAs, HPLC, LC-MS, and batch records, so research [...] Aug How Peptide Cold Packaging Works in Transit Learn how peptide cold packaging works, from insulation and gel packs to route planning, temperature [...] Jul How to Choose Research Peptides for Reliable Studies Learn how to choose research peptides by reviewing identity, purity, batch documentation, packaging, storage, and [...] Jul Retatrutide Analytical Handling Guide for Labs Use this retatrutide analytical handling guide to support traceable receiving, storage, sampling, and documentation for [...] Jul What Does Research Grade Mean for Peptides
Ingredient approaches To make the complex science of GLP-1 more approachable, it helps to focus on how a handful of key ingredient categories interact with the gut-brain axis
Buyer Takeaway: Compounded injectable GLP-1s require self-measurement from a vial - a meaningfully different administration process from brand-name pre-filled auto-injectors
World renowned tennis star Serena Willams is partnering with the brand as its newest ambassador to talk about her journey with GLP-1s
The process seems straightforward, but it meets a difficulty known as first-pass metabolism
Reported benefits (per available research): Reliably studied for its ability to increase circulating growth hormone (and downstream IGF-1) in both animal models and a human Phase II trial, where it was well tolerated but did not significantly outperform placebo on its primary clinical endpoint Studied in rodent models for effects on bone formation and bone mineral content, including in a glucocorticoid-induced bone-loss model, though this evidence is animal-only and has not been confirmed in controlled human trials Anecdotally and in early/limited research associated with changes in body composition (lean mass, fat mass) and subjective sleep quality, but these claims rely mostly on user reports and small or non-peer-reviewed data rather than robust human clinical trials Known risks and side effects: FDA safety reviewers flagged growth-hormone-secretagogue peptides in this family for potential cardiovascular effects (e.g., increased heart rate, vasodilatory reactions such as flushing and transient hypotension) as part of the rationale for restricting compounding Commonly reported effects include headache, injection-site reactions, and mild fluid retention or bloating tied to growth-hormone-mediated fluid balance changes Because it is sold as an unregulated research chemical outside pharmaceutical manufacturing controls, there is added risk from impurities, mislabeled concentration, and lack of quality assurance, and long-term human safety data remain limited or absent Evidence snapshot: The strongest human evidence is a randomized, double-blind, placebo-controlled Phase II trial (ClinicalTrials.gov NCT00672074) in bowel-resection patients showing ipamorelin was well tolerated but not significantly more effective than placebo for postoperative ileus
